Prenatal diethylstilbestrol exposure and risk of breast cancer.

Prenatal diethylstilbestrol exposure and risk of breast cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prenatal diethylstilbestrol exposure and risk of breast cancer. Abstract Text:

Julie R Palmer,Lauren A Wise,Elizabeth E Hatch,Rebecca Troisi,Linda Titus-Ernstoff,William Strohsnitter,Raymond Kaufman,Arthur L Herbst,Kenneth L Noller,Marianne Hyer,Robert N Hoover,

It has been hypothesized that breast cancer risk is influenced by prenatal hormone levels. Diethylstilbestrol (DES), a synthetic estrogen, was widely used by pregnant women in the 1950s and 1960s. Women who took the drug have an increased risk of breast cancer, but whether risk is also increased in the daughters who were exposed in utero is less clear. We assessed the relation of prenatal DES exposure to risk of breast cancer in a cohort of DES-exposed and unexposed women followed since the 1970s by mailed questionnaires. Eighty percent of both exposed and unexposed women completed the most recent questionnaire. Self-reports of breast cancer were confirmed by pathology reports. Cox proportional hazards regression was used to compute incidence rate ratios (IRR) for prenatal DES exposure relative to no exposure. During follow-up, 102 incident cases of invasive breast cancer occurred, with 76 among DES-exposed women (98,591 person-years) and 26 among unexposed women (35,046 person-years). The overall age-adjusted IRR was 1.40 [95% confidence interval (95% CI), 0.89-2.22]. For breast cancer occurring at ages >or=40 years, the IRR was 1.91 (95% CI, 1.09-3.33) and for cancers occurring at ages >or=50 years, it was 3.00 (95% CI, 1.01-8.98). Control for calendar year, parity, age at first birth, and other factors did not alter the results. These results, from the first prospective study on the subject, suggest that women with prenatal exposure to DES have an increased risk of breast cancer after age 40 years. The findings support the hypothesis that prenatal hormone levels influence breast cancer risk.

Prenatal diethylstilbestrol exposure and risk of breast cancer. Publishing Authors By Initials

JR Palmer,LA Wise,EE Hatch,R Troisi,L Titus-Ernstoff,W Strohsnitter,R Kaufman,AL Herbst,KL Noller,M Hyer,RN Hoover,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prenatal diethylstilbestrol exposure and risk of breast cancer. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Cancer epidemiology, biomarkers & prevention : a p

VOLUME: 15

Page Numbers: 1509-14

Journal Abbreviation:

ISSN: 1055-9965

DAY: 3

MONTH: Aug

YEAR: 2006

Prenatal diethylstilbestrol exposure and risk of breast cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9200608

Prenatal diethylstilbestrol exposure and risk of breast cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prenatal diethylstilbestrol exposure and risk of breast cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prenatal diethylstilbestrol exposure and risk of breast cancer.

AFFILIATION: Slone Epidemiology Center, Boston University, 1010 Commonwealth Avenue, Boston, MA 02215, USA. jpalmer@slone.bu.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Epidemiol Biomarkers Pr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prenatal diethylstilbestrol exposure and risk of breast cancer Related Publications

• Aerosol dosimetry research needs.
• Bereavement, gender, and cyberspace: a content analysis of parents' memorials to their children.
• Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
• Carcinoma of the epiglottis treated by surgical excision with operative technic.
• Community as a key to healing after the death of a child.
• Direct analysis of the extracellular proteome from two strains of Helicobacter pylori.
• Effect of stimulus bandwidth on auditory skills in normal-hearing and hearing-impaired children.
• Efficient in vitro amplification of chronic wasting disease PrPRES.
• Empowerment will improve patient safety.
• Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant.
• Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary.
• FOOD CONSERVATION AND THE WAR.
• High-risk benign breast lesions: current strategies in management.
• Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations.
• Look, no hands! Unconventional transcriptional activators in bacteria.
• Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).
• Mortality in women given diethylstilbestrol during pregnancy.
• PUBLIC HEALTH ENGINEERING: SEWAGE SLUDEG.
• Patient safety and surgeons: why the resistance?
• Phorbol ester stimulation of RasGRP1 regulates the sodium-chloride cotransporter by a PKC-independent pathway.
• Preeclampsia risk in women exposed in utero to diethylstilbestrol.
• Prenatal diethylstilbestrol exposure and risk of breast cancer.
• Shuttle lock release modification of a trans-tibial prosthesis with an obese client.
• Solar ultraviolet irradiation of human cornea, lens, and retina: equations of ocular irradiation.
• Surgeon Eddie L. Hoover, MD: Editor-in-Chief of the Journal of the National Medical Association from 2004 to present. Interview by George Dawson.
• The defining role of structure (including epitaxy) in the plausibility of homeopathy.
• Use of nisin-coated plastic films to control Listeria monocytogenes on vacuum-packaged cold-smoked salmon.
• Use of soy proteins in baked foods.
• Use of soy proteins in bakery products.
• Youth and chemical dependence.